Rogerio C. Lilenbaum, MD, discusses the rise of immunotherapy in non–small cell lung cancer.
Rogerio C. Lilenbaum, M
Advertisement
Articles by Rogerio C. Lilenbaum, M
Advertisement
Latest Updated Articles
Dr. Lilenbaum on the Rise of Immunotherapy in NSCLCPublished: May 16th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5